Rambam Health Care Campus commonly called Rambam Hospital, is a hospital in the Bat Galim neighborhood of Haifa, Israel founded in 1938, 10 years before the establishment of the State of Israel.

There are 1,040 beds in Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402).

During the past decade, Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)" are "Carcinoma, Ovarian Epithelial" (1 trials), "Endometrial Neoplasms" (1 trials), "Fallopian Tube Neoplasms" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)" in a lesser frequency.

Most popular intervention types in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Paclitaxel" (1 trials), "Pembrolizumab" (1 trials) and "Placebo for pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".